● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

IPCALAB

BSE
IPCA Laboratories Limited
Healthcare· Pharmaceuticals & Biotechnology· INE571A01038· Scrip: 524494
ENहिन्दीગુજરાતીमराठी
1,634.25
1.40 (+0.00%)
2026-06-10
BSE
1,634.25
1.40
+0.00%
1,2621,3631,4631,5641,66406-1308-0710-0612-0201-2904-0106-10
234 trading days · 1Y period
TODAY (BSE)
Open1,623.60
High1,659.25
Low1,620.00
Prev Close1,635.65
Volume5,613
Value₹0.9Cr
L: 1,620.00H: 1,659.25
Info
Face Value₹1
Listed1995-02-08
ISININE571A01038
SeriesA
BSE Scrip524494

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue-4.65%
PAT+12.46%
EPS+8.07%
Profitability
Dividend
Growth+0.00%
TTM Revenue
₹8199 Cr
TTM EBITDA
₹1768 Cr
TTM PAT
₹728 Cr
TTM EPS
₹29.23
Rev/Share
₹323.2

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr589 Cr1177 Cr1766 Cr2355 Cr22-1223-0323-0923-1224-0324-0624-0924-124.33.05.77.12.48.19.19.8
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-312245 Cr1898 Cr574 Cr368 Cr276 Cr9.78
2024-09-302355 Cr2036 Cr567 Cr345 Cr246 Cr9.05
2024-06-301566 Cr1293 Cr349 Cr288 Cr204 Cr8.05
2024-03-312033 Cr1839 Cr278 Cr77 Cr1 Cr2.35
2023-12-312053 Cr1854 Cr488 Cr289 Cr221 Cr7.09
2023-09-302034 Cr1847 Cr448 Cr225 Cr136 Cr5.72
2023-03-311512 Cr1419 Cr266 Cr129 Cr78 Cr3.02
2022-12-311546 Cr1408 Cr300 Cr169 Cr110 Cr4.25

Shareholding Pattern

CURRENT2026-03-31
44.7%PROMOTER
Promoter44.7%
FII10.6%
DII37.5%
Public55.3%
PROMOTER HOLDING TREND
46.3%24-0646.3%24-0944.7%24-1244.7%25-0344.7%25-0944.7%25-1244.7%26-03

Corporate Actions

Ex-DateTypePurpose
2025-08-05DividendDividend - Rs 2 Per Share
2024-11-27DividendInterim Dividend - Rs 2 Per Share
2024-08-06DividendAnnual General Meeting/Dividend - Rs 2 Per Share
2023-11-22DividendInterim Dividend - Rs 2 Per Share
2022-11-22DividendInterim Dividend - Rs 4 Per Share
2022-08-03OtherAnnual General Meeting
2022-01-10SplitFace Value Split (Sub-Division) - From Rs 2/- Per Share To Re 1/- Per Share
2021-11-22Dividend Interim Dividend - Rs 8 Per Share
2021-08-26Other Annual General Meeting
2020-11-13Dividend Interim Dividend - Rs 8 Per Share
2020-09-10Other Annual General Meeting
2020-02-18Dividend Interim Dividend - Rs 5 Per Share
2019-08-06Dividend Annual General Meeting/Dividend - Rs 3 Per Share
2018-08-02Dividend Annual General Meeting/Dividend- Re 1 Per Share
2017-07-27Dividend Annual General Meeting/Dividend - Re 1/- Per Share
2016-08-04Other Annual General Meeting
2015-07-22DividendAnnual General Meeting / Dividend - Re 1/- Per Share
2014-07-18DividendAnnual General Meeting / Final Dividend - Rs 2.50/- Per Share
2013-10-31DividendInterim Dividend Rs.2.50 Per Share (Purpose Revised)
2013-07-19DividendAnnual General Meeting/Dividend Rs 2/- Per Share

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-101,641.501,658.901,621.001,630.201.72L
2026-06-031,507.701,562.101,499.101,554.702.74L
2026-05-271,577.001,592.401,567.001,572.4074,100
2026-05-261,566.201,599.901,565.601,578.001.36L
2026-05-251,609.901,617.801,565.201,571.001.09L
2026-05-221,648.501,648.501,596.501,602.101.00L
2026-05-211,650.001,660.001,619.001,637.002.21L
2026-05-201,647.901,678.301,635.301,646.602.73L
2026-05-191,651.001,662.201,634.001,656.202.57L
2026-05-181,585.001,658.001,585.001,646.306.35L
2026-05-151,592.701,654.701,584.801,605.0011.14L
2026-05-141,510.001,593.801,510.001,583.905.44L
2026-05-131,518.001,538.901,494.001,506.302.51L
2026-05-121,535.001,544.801,499.001,509.105.07L
2026-05-111,557.201,569.001,525.201,535.005.33L
2026-05-081,560.101,610.501,545.601,552.602.48L
2026-05-071,572.201,590.401,555.101,560.1097,347
2026-05-061,548.001,581.001,542.001,564.402.41L
2026-05-051,535.001,559.001,513.601,541.801.83L
2026-05-041,538.001,574.101,525.001,530.001.28L
2026-04-301,542.101,590.001,524.301,530.903.49L
2026-04-291,542.801,552.101,522.601,542.101.29L
2026-04-281,548.001,573.901,530.201,537.0099,425
2026-04-271,557.101,585.901,528.501,541.302.41L
2026-04-241,535.001,573.201,516.001,555.902.31L
2026-04-231,494.601,541.101,486.301,526.102.48L
2026-04-221,476.501,514.001,466.501,494.803.10L
2026-04-211,469.901,491.001,462.101,476.501.99L
2026-04-201,460.001,488.901,447.701,468.601.69L
2026-04-171,461.001,475.001,456.201,468.301.15L

Frequently Asked Questions

About

IPCA Laboratories Limited, an Indian multinational pharmaceutical company based in Mumbai, specializes in producing high-quality APIs such as theobromine, acetylthiophene, and p-bromotoluene. Known for its commitment to quality and safety, the company has been a consumer-led global pharmaceutical leader since its inception in 1949.

BOARD OF DIRECTORS
Ajit Kumar Jain
Managing Director
Pranay Godha
Managing Director
Kamal Kishore Seth
Independent Director
Narendra Mairpady
Independent Director
Ramakanta Panda
Independent Director
DEPARTED

Mutual Fund Holdings

8 funds · bar length = % to NAVBrowse all funds →
hdfc3 schemes
HDFC Mid Cap Fund
3.38%
₹28.8K Cr
HDFC Large and Mid Cap Fund
0.89%
₹2.3K Cr
HDFC NIFTY MIDCAP 150 INDEX FUND
0.63%
₹3 Cr
baroda4 schemes
Baroda BNP Paribas Health and Wellness Fund
0.05%
₹27 Cr
Baroda BNP Paribas Mid Cap Fund
0.02%
₹48 Cr
Baroda BNP Paribas Manufacturing Fund
0.02%
₹13 Cr
dsp1 scheme
DSP Regular Savings Fund
0.00%
₹1 Cr